Search Results - "Horner, Faye"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Real-World Visual And Clinical Outcomes For Patients With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab: An 8-Year Observational Cohort (AMD8) by Horner, Faye, Lip, Peck-Lin, Clark, Hannah, Chavan, Randhir, Sarmad, Ambreen, Mushtaq, Bushra

    Published in Clinical ophthalmology (Auckland, N.Z.) (01-12-2019)
    “…To report the long-term clinical outcomes for patients with neovascular age-related macular degeneration (nAMD) who received anti-vascular endothelial growth…”
    Get full text
    Journal Article
  2. 2

    Novel non-sense mutation in RP2 (c.843_844insT/p.Arg282fs) is associated with a severe phenotype of retinitis pigmentosa without evidence of primary retinal pigment epithelium involvement by Horner, Faye, Wawrzynski, James, MacLaren, Robert E

    Published in BMJ case reports (01-05-2019)
    “…Retinitis pigmentosa (RP) relates to a heterogeneous group of rod-cone dystrophies of varying genetic aetiology. There is currently great interest in gene…”
    Get full text
    Journal Article
  3. 3

    Comparing Effectiveness of Three Different Anti-VEGF Treatment Regimens for Neovascular Age-Related Macular Degeneration: Two Years' Real-World Clinical Outcomes by Horner, Faye, Lip, Peck Lin, Mohammed, Bashar R, Fusi-Rubiano, William, Gokhale, Eesha, Mushtaq, Bushra, Chavan, Randhir

    Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2021)
    “…To compare and report the 2-year treatment outcomes from 3 different anti-VEGF treatment regimens in treating neovascular aged-related macular degeneration…”
    Get full text
    Journal Article
  4. 4

    Combination Therapy for Macular Oedema in Retinal Vein Occlusions: 3-Year Results from a Real-World Clinical Practice by Horner, Faye, Lip, Peck Lin, Mushtaq, Bushra, Chavan, Randhir, Mohammed, Bashar, Mitra, Arijit

    Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2020)
    “…To report long-term efficacy and treatment outcomes of the combination therapy for treating macular oedema (MO) in retinal vein occlusions (RVOs) from a…”
    Get full text
    Journal Article